Novo Nordisk invests $1.05B in Brazil factory to boost GLP-1 drug production, including Wegovy and Ozempic, creating 600 jobs ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

Novo Nordisk (NVO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...

Novo Nordisk (NYSE:NVO) today announced the sales and operating profit growth at constant exchange rates (CER) for the first ...

COPENHAGEN (Reuters) -Novo Nordisk on Friday raised its outlook for its full-year sales and operating profit for the third time ...

FRANKFURT/LONDON: European pharma companies warned the European Commission president at a meeting on Tuesday that U.S. tariffs would expedite the industry’s shift away from Europe and toward the ...

By Sukriti Gupta (Reuters) -European shares fell on Wednesday as the rollout of steep U.S. retaliatory tariffs deepened fears ...

The price of West Texas Intermediate, the US benchmark, fell briefly below $60 a barrel, wiping out earlier gains. Brent crude was down 1.5 per cent at $63.26 at four-year lows during afternoon ...

Beijing raises its levy on US imports from 34%, after the US president's 104% tariff on China kicked in today.

Trump says the tariffs are "explosive" as taxes on 60 countries - who he deems to be the "worst offenders" - kick in.

European stocks slumped on Wednesday as US President Donald Trump’s tariffs took effect, triggering a renewed selloff across ...